BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

461 related articles for article (PubMed ID: 6966403)

  • 1. Autoantibody to centromere (kinetochore) in scleroderma sera.
    Moroi Y; Peebles C; Fritzler MJ; Steigerwald J; Tan EM
    Proc Natl Acad Sci U S A; 1980 Mar; 77(3):1627-31. PubMed ID: 6966403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Anti-Scl-70 and anti-centromere autoantibodies. Biological markers of 2 forms of systemic scleroderma].
    Johanet C; Agostini MM; Vayssairat M; Abuaf N
    Presse Med; 1989 Feb; 18(5):207-11. PubMed ID: 2522207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteins responsible for anticentromere activity found in the sera of patients with CREST-associated Raynaud's phenomenon.
    Kremer L; Alvaro-Gracia JM; Ossorio C; Avila J
    Clin Exp Immunol; 1988 Jun; 72(3):465-9. PubMed ID: 3048807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serological markers in progressive systemic sclerosis: clinical correlations.
    Catoggio LJ; Bernstein RM; Black CM; Hughes GR; Maddison PJ
    Ann Rheum Dis; 1983 Feb; 42(1):23-7. PubMed ID: 6402991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anticentromere antibody and immunoglobulin allotypes in scleroderma.
    Chen ZY; Fedrick JA; Pandey JP; Silver R; Maricq HR; Fudenberg HH; Dobson RL; Ainsworth SK
    Arch Dermatol; 1985 Mar; 121(3):339-44. PubMed ID: 3883903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A long-term longitudinal study of anticentromere antibodies.
    Tramposch HD; Smith CD; Senecal JL; Rothfield N
    Arthritis Rheum; 1984 Feb; 27(2):121-4. PubMed ID: 6607733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-kinetochore directed autoantibodies in scleroderma/CREST. Identification of an activity recognizing a metaphase chromosome core non-histone protein.
    Jeppesen P; Nicol L
    Mol Biol Med; 1986 Aug; 3(4):369-84. PubMed ID: 3095608
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human anti-centromere sera recognise a 19.5 kD non-histone chromosomal protein from HeLa cells.
    Guldner HH; Lakomek HJ; Bautz FA
    Clin Exp Immunol; 1984 Oct; 58(1):13-20. PubMed ID: 6383665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A highly conserved 72,000 dalton centromeric antigen reactive with autoantibodies from patients with progressive systemic sclerosis.
    McNeilage LJ; Whittingham S; McHugh N; Barnett AJ
    J Immunol; 1986 Oct; 137(8):2541-7. PubMed ID: 3531335
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential isotype recognition of two centromere associated polypeptides by immunoblotting in connective tissue disease.
    McHugh NJ; James IE; Maddison PJ
    Clin Exp Immunol; 1988 Jun; 72(3):457-64. PubMed ID: 3048806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tubulin interaction with kinetochore proteins: analysis by in vitro assembly and chemical cross-linking.
    Balczon RD; Brinkley BR
    J Cell Biol; 1987 Aug; 105(2):855-62. PubMed ID: 3305522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Three human chromosomal autoantigens are recognized by sera from patients with anti-centromere antibodies.
    Earnshaw W; Bordwell B; Marino C; Rothfield N
    J Clin Invest; 1986 Feb; 77(2):426-30. PubMed ID: 3511098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Centromere antibodies and antibodies against Scl 70 nucleoprotein in progressive systemic scleroderma. Diagnostic and prognostic significance].
    Meurer M; Scharf A; Luderschmidt C; Braun-Falco O
    Dtsch Med Wochenschr; 1985 Jan; 110(1):8-14. PubMed ID: 3880700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autoantibodies in scleroderma.
    Pollard KM; Reimer G; Tan EM
    Clin Exp Rheumatol; 1989; 7 Suppl 3():S57-62. PubMed ID: 2691161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunological characterization of heterochromatin protein p25beta autoantibodies and relationship with centromere autoantibodies and pulmonary fibrosis in systemic scleroderma.
    Furuta K; Hildebrandt B; Matsuoka S; Kiyosawa K; Reimer G; Luderschmidt C; Chan EK; Tan EM
    J Mol Med (Berl); 1998 Jan; 76(1):54-60. PubMed ID: 9462868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anticentromere and anticentriole antibodies in the scleroderma spectrum.
    Tuffanelli DL; McKeon F; Kleinsmith DM; Burnham TK; Kirschner M
    Arch Dermatol; 1983 Jul; 119(7):560-6. PubMed ID: 6859899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of double minutes and double minute-like chromatin in human and murine tumor cells using antikinetochore antibodies.
    Haaf T; Schmid M
    Cancer Genet Cytogenet; 1988 Jan; 30(1):73-82. PubMed ID: 3275490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Significance of anti-centromere antibodies. Clinical value].
    Meyer O; Haim T; Ryckewaert A
    Rev Rhum Mal Osteoartic; 1983 Apr; 50(4):261-6. PubMed ID: 6348931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The CREST syndrome: a distinct serologic entity with anticentromere antibodies.
    Fritzler MJ; Kinsella TD
    Am J Med; 1980 Oct; 69(4):520-6. PubMed ID: 6968511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The analysis of antinuclear and antinucleolar autoantibodies of scleroderma by radioimmunoprecipitation assays.
    Kipnis RJ; Craft J; Hardin JA
    Arthritis Rheum; 1990 Sep; 33(9):1431-7. PubMed ID: 2403405
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.